Equity Research & Insights
Woodford Sells Glaxo, Buys Lloyds
Market News - May 12, 2017
Star fund manager Neil Woodford has sold out of GlaxoSmithKline (GSK) in his flagship fund Woodford Equity Income and bought into Lloyds Bank (LLOY), and housebuilders Barratt Developments (BDEV) and Taylor Wimpey (TW.). Other additions to the portfolio include Forterra, a UK brick manufacturer, student accommodation developer, Watkin Jones, construction materials businesses Eurocell and Topps Tiles, real estate businesses British Land, Hansteen, Londonmetric and Sirius Real Estate, technology service companies Softcat and Micro Focus and...
Why Dividends from UK Stocks are High Risk Investments
Market News - April 13, 2017
UK stocks have rallied considerably over the past year, and anyone who was brave enough to back the market before the Brexit vote has made great gains. But the bull market has hidden a number of threats to both the UK economy and domestically focused stocks, says Securities Trust of Scotland (STS) fund manager Mark Whitehead. “There has been a rise of ‘animal spirits’ among investors over the past 12 months,” he said. “But we...
Which Stock Dividends are Safe?
Market News - September 28, 2016
Investors should question the sustainability of dividend income from pharmaceutical stocks, banks and mining companies says Gold Rated Henderson investor Job Curtis When Job Curtis took over the management of The City of London Investment Trust(CTY) 25 years ago, the annual dividend was 4p per share. Now the closed-end pays out that amount in a quarterly dividend every three months. Curtis and his predecessor have managed to grow the dividend for City of...